• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Acetylsalicylic Acid

Acetylsalicylic Acid

Product ID A0819
Cas No. 50-78-2
Purity ≥98%
Product Unit SizeCostQuantityStock
100 g $39.00 In stock
250 g $52.00 In stock
500 g $79.00 In stock
1 kg $136.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Acetylsalicylic acid (aspirin) is a non-steroidal anti-inflammatory drug (NSAID) that is somewhat selective in inhibiting COX-1 over COX-2. Aspirin exhibits anti-inflammatory, analgesic, antipyretic, chemopreventive, cardioprotective, and anticoagulant/antithrombotic activities. Aspirin is clinically used to treat inflammation, fever, pain, and other disorders. Long-term use of aspirin is associated with decreased risk of colorectal and other cancers as well as cardiovascular events such as myocardial infarction. Aspirin also decreases levels of thromboxane A2 (TxA2), inhibiting platelet aggregation and prolonging bleeding time.

Product Info

Cas No.

50-78-2

Purity

≥98%

Formula

C9H8O4

Formula Wt.

180.16

Chemical Name

2-(Acetyloxy)benzoic acid

IUPAC Name

2-acetyloxybenzoic acid

Synonym

Salicylic acid acetate; aspirin

Melting Point

136-140°C

Solubility

Soluble in ethanol (200 mg/mL), DMSO or water (3.3 mg/mL).

Appearance

White granular powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

A0819 MSDS PDF

Info Sheet

A0819 Info Sheet PDF

Brochures

NSAID Flyer

References

Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 2012 May;13(5):518-27. PMID: 22440112.

Bartfai T, Conti B. Fever. ScientificWorldJournal. 2010 Mar 16;10:490-503. PMID: 20305990.

Antithrombotic Trialists' (ATT) Collaboration: Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009 May 30;373(9678):1849-60. PMID: 9482214.

Tohgi H, Konno S, Tamura K, et al. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. Stroke. 1992 Oct;23(10):1400-3. PMID: 1412574.

Li W, Li J, Ashok M, et al. A cardiovascular drug rescues mice from lethal sepsis by selectively attentuating a late-acting proinflammatory mediator, high mobility group box 1. J Immunol. 2007 Mar 15;178(6):3856-3864. PMID: 17339485.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • G3553

    Ginsenoside Rb2

    Triterpene saponin found in species of Panax.

    ≥98%
  • T0008

    Tacrolimus

    Calcineurin inhibitor.

    ≥98%
  • S8145

    Sulindac

    NSAID; COX-1/2 and PDE inhibitor.

    ≥99%
  • D023721

    Dasatinib

    Multikinase inhibitor.

    ≥99%
  • A9814

    AZD-4547

    FGFR inhibitor.

    ≥98%
  • M1977

    Metronidazole

    Nitroimidazole; DNA synthesis inhibitor.

    ≥98%
  • H9726

    Hygromycin B

    Protein translocation inhibitor.

    ≥95.0%
  • T5869

    Torcetrapib

    Cholesterol ester transfer protein inhibitor.

    ≥98%
  • D0025

    DAMGO

    Synthetic peptice; μOR agonist.

    ≥95%
  • L0226

    Lagochiline

    Diterpene alkaloid found in Lagochilus.

    ≥98%
  • C0275

    Castanospermine

    O-GlcNAcase inhibitor.

    ≥98%
  • L5767

    Loratadine

    Histamine H1 antagonist, FIASMA.

    ≥98%
  • M0275

    Mastoparan 17

    Peptide, inactive mastoparan analog used to mea...

    ≥95%
  • K040009

    KB-0742 dihydrochloride

    CDK9 inhibitor.

    ≥99%
  • A6058

    Apoptosis Activator 2

    Apoptosis inducing agent.

    ≥98%
  • S1968

    Seratrodast

    TxA2 antagonist.

    ≥99%
  • T1654

    Tenoxicam

    NSAID; COX-1/2 inhibitor.

    ≥98%
  • S543721

    SNS-032

    Inhibitor of CDK.

    ≥99%
  • C0155

    10-Hydroxycamptothecin

    Camptothecin derivative; topoisomerase I inhibi...

    ≥98%
  • A4000

    AK-1

    SIRT2 inhibitor.

    ≥99%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only